CCO Independent Conference Coverage

2008 American Society of Clinical Oncology Annual Meeting*

May 30-June 3, 2008 | McCormick Place, Chicago, Illinois

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Breast Cancer

Track 1 of 6

Program Director: Ramaswamy Govindan, MD

Faculty:
		William J. Gradishar, MD, FACP Clifford A. Hudis, MD Kathy D. Miller, MD
		Christy Russell, MD

Gastrointestinal Cancers

Track 2 of 6

Program Director: Ramaswamy Govindan, MD

Faculty:
		Richard M. Goldberg, MD Axel Grothey, MD John L. Marshall, MD
		Robert S. Mocharnuk, MD

Genitourinary Cancers

Track 3 of 6

Program Director: Ramaswamy Govindan, MD

Faculty:
		David I. Quinn, MD, PhD Brian I. Rini, MD Nicholas J. Vogelzang, MD
		Robert S. Mocharnuk, MD

Hematologic Malignancies

Track 4 of 6

Capsule Summaries

Expert Analysis

Program Director: Ramaswamy Govindan, MD

Faculty:
		Andre Goy, MD, MPH Hagop M. Kantarjian, MD Sagar Lonial, MD
		Robert S. Mocharnuk, MD

Lung Cancer

Track 5 of 6

Program Director: Ramaswamy Govindan, MD

Faculty:
		David R. Gandara, MD Thomas J. Lynch, MD Alan B. Sandler, MD

Expert Highlights

Choose a highlight from the list below:

Expert Highlight: Breast Cancer

Kathy D. Miller, MD, provides an update on the top issues in adjuvant therapy including hormone therapy, bone loss treatments, and vitamin D status. She also discusses the impact of biologic agents targeting VEGF and EGFR on therapy for metastatic disease. (12 minutes)

Windows Media 24.9 MB

Quicktime Video 17.2 MB

iPod Video 141.6 MB

Audio 11.3 MB

Expert Highlight: Breast Cancer

Expert Highlight: Gastrointestinal Cancers

Expert Highlight: Genitourinary Cancers

Expert Highlight: Hematologic Malignancies

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

CCO Independent Conference Coverage

2008 American Society of Clinical Oncology Annual Meeting*

May 30-June 3, 2008 | McCormick Place, Chicago, Illinois

Breast Cancer

Track 1 of 6

Faculty:

Gastrointestinal Cancers

Track 2 of 6

Faculty:

Genitourinary Cancers

Track 3 of 6

Faculty:

Hematologic Malignancies

Track 4 of 6

Faculty:

Lung Cancer

Track 5 of 6

Faculty:

Ovarian Cancer

Track 6 of 6

Expert Highlights

Choose a highlight from the list below:

Expert Highlight: Breast Cancer

Kathy D. Miller, MD, provides an update on the top issues in adjuvant therapy including hormone therapy, bone loss treatments, and vitamin D status. She also discusses the impact of biologic agents targeting VEGF and EGFR on therapy for metastatic disease. (12 minutes)

Expert Highlight: Breast Cancer

Kathy D. Miller, MD

Expert Highlight: Gastrointestinal Cancers

Expert Highlight: Genitourinary Cancers

Brian I. Rini, MD

Expert Highlight: Hematologic Malignancies

Hagop M. Kantarjian, MD

Expert Highlight: Lung Cancer

Ramaswamy Govindan, MD

Educational grants provided by:

Capsule Summary:

In SWOG Phase III Trial, Irinotecan/Cisplatin Fails to Demonstrate Survival Advantage Over Etoposide/Cisplatin in Extensive SCLC